ACTAVIS is the world’s third-largest global generic pharmaceutical company. The company portfolio includes more than 750 products. ACTAVIS develops brand products, including innovative ones in 18 R&D sites located in USA, Europe and Asia. 32 manufacturing facilities around the world produce medicines according to GMP, EMEA and FDA USA requirements. ACTAVIS has commercial operations in more than 60 countries with a leading position in the most of key markets. The Company international headquarters is located in Zug, Switzerland. ACTAVIS Russia provides patients suffered cardiovascular diseases with the high-quality and affordable treatment. VALZ (valsartan), VALZ H (valsartan + hydrochlorothiazide), LOPIREL (clopidogrel) and CORDINORM (bisoprolol) proved the high confidence of Russian healthcare professionals and patients. Also in Russia ACTAVIS has wide range of OTC and neurology products. All employees perform high-professionally, customer-oriented and responsibly.
Address: 40/4 B. Ordynka, Moscow, Russia, 119017
Phone: +7 (495) 644-44-14, fax: +7 (495) 644-44-24